Annexes to COM(2024)2 - EU position in the sixty-seventh session of the Commission on Narcotic Drugs on the scheduling of substances under the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the Convention on Psychotropic Substances of 1971

Please note

This page contains a limited version of this dossier in the EU Monitor.

dossier COM(2024)2 - EU position in the sixty-seventh session of the Commission on Narcotic Drugs on the scheduling of substances under the Single ...
document COM(2024)2 EN
date March  4, 2024
Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of new psychoactive substances in the definition of ‘drug’ (OJ L 200, 29.7.2022, p. 148).


ANNEX

Position to be taken by the Member States that are members of the Commission on Narcotic Drugs, acting jointly, in the interest of the Union, during the 67th session of the Commission on Narcotic Drugs from 14 to 22 March 2024 on the scheduling of substances:

(1)Bromazolam is to be included in Schedule IV of the Convention on Psychotropic Substances;

(2)Butonitazene is to be included in the Schedule I of the Convention on Narcotic Drugs;

(3)3-Chloromethcathinone (3-CMC) is to be included in Schedule II of the Convention on Psychotropic Substances;

(4)Dipentylone is to be included in Schedule II of the Convention on Psychotropic Substances;

(5)2-Fluorodeschloroketamine (2-FDCK) is to be included in Schedule II of the Convention on Psychotropic Substances.


ELI: http://data.europa.eu/eli/dec/2024/832/oj

ISSN 1977-0677 (electronic edition)